Funding

0 shares

CDMRP Ovarian Cancer Omics Consortium Award

By Dept. of the Army -- USAMRAA
Government Grant

$6,040,000

deadline:

07/08/21

Description

Applications to the Fiscal Year 2021 (FY21) Ovarian Cancer Research Program (OCRP) are being solicited for the Defense Health Agency (DHA) J9, Research and Development Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by United States Code, Title 10, Section 2358 (10 USC 2358). As directed by the Office of the Assistant Secretary of Defense for Health Affairs (OASD[HA]), the DHA manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The execution management agent for this program announcement is the Congressionally Directed Medical Research Programs (CDMRP). The OCRP was initiated in FY97 to provide support for research of exceptional scientific merit. Appropriations for the OCRP from FY97 through FY20 totaled $371.45 million (M). The FY21 appropriation is $35.0M.

Thanks to the funder for their generosity.